A randomized, double-blind, placebo-controlled study of the safety and tolerability of Study Drug and its effects on biomarkers in subjects with coronary artery disease.
We’ve contributed to the successful approval of eight marketed cardio-metabolic drugs.
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…
Ask the Experts: Insights on NASH and the Current Research and Treatments
NASH (Non-Alcoholic Steatohepatitis) is a rising disease that is sweeping the population. It is a terminal diagnosis that currently requires a liver…